Blog Posts

Evaluating Pregabalin for Chronic Cough in Lung Cancer

Non-Small Cell Lung Cancer/LinkedIn

Nov 30, 2024, 22:15

Evaluating Pregabalin for Chronic Cough in Lung Cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X:

“Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial.

Pregabalin does not significantly decrease cough in patients with lung cancer. Systemic cancer-directed therapy is the most effective antitussive.”

Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial

Authors: Vanita Noronha, Nandini Menon, Vijay M. Patil, Minit Shah, Amit Joshi, Srushti Shah, Kavita Nawale, Rohan Surve, Gunj Bafna, Shweta Jogdhankar, Priyanka Shelar, Ankush Shetake, Ashish Singh, Sushmita Salian, Pundlik Jadhav, Hetakshi Shah, Neha Mer, Ananya Vohra, Swaratika Majumdar, Shripad Banavali, Rajendra Badwe & Kumar Prabhash

Evaluating Pregabalin for Chronic Cough in Lung Cancer

antitussive cancer cancer care Cancer research cancer survivorship cancer treatment cancer-directed therapy chronic cough double-blind trial health outcomes Lung cancer lung cancer patients lung cancer treatment medical oncology OncoDaily Oncology oncology research pharmacology placebo-controlled trial pregabalin randomized trial respiratory therapy systemic therapy Yakup Ergün

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter